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The Multiple Biological Roles of the 335 Exonuclease of
Saccharomyces cerevisiae DNA Polymerase  Require
Switching between the Polymerase and
Exonuclease Domains
Yong Hwan Jin,1†‡ Parie Garg,2† Carrie M. W. Stith,2 Hanan Al-Refai,1‡
Joan F. Sterling,1 Laura J. W. Murray,1§ Thomas A. Kunkel,1
Michael A. Resnick,1 Peter M. Burgers,2*†
and Dmitry A. Gordenin1*†
Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, Research Triangle
Park, North Carolina,1 and Department of Biochemistry and Molecular Biophysics, Washington
University School of Medicine, St. Louis, Missouri2
Received 20 July 2004/Returned for modification 23 September 2004/Accepted 30 September 2004
Until recently, the only biological function attributed to the 335 exonuclease activity of DNA polymerases
was proofreading of replication errors. Based on genetic and biochemical analysis of the 335 exonuclease of
yeast DNA polymerase  (Pol ) we have discerned additional biological roles for this exonuclease in Okazaki
fragment maturation and mismatch repair. We asked whether Pol  exonuclease performs all these biological
functions in association with the replicative complex or as an exonuclease separate from the replicating
holoenzyme. We have identified yeast Pol  mutants at Leu523 that are defective in processive DNA synthesis
when the rate of misincorporation is high because of a deoxynucleoside triphosphate (dNTP) imbalance. Yet
the mutants retain robust 335 exonuclease activity. Based on biochemical studies, the mutant enzymes
appear to be impaired in switching of the nascent 3 end between the polymerase and the exonuclease sites,
resulting in severely impaired biological functions. Mutation rates and spectra and synergistic interactions of
the pol3-L523X mutations with msh2, exo1, and rad27/fen1 defects were indistinguishable from those observed
with previously studied exonuclease-defective mutants of the Pol . We conclude that the three biological
functions of the 335 exonuclease addressed in this study are performed intramolecularly within the repli-
cating holoenzyme.
DNA replication errors are an important source of genetic
change. Several biochemical activities have evolved in order to
prevent errors from becoming mutations. One is the 335
exonuclease (Exo) activity present in many DNA polymerases
(Pol). A well-established function for this exonuclease activity
is the proofreading of errors made by the DNA polymerase (6,
27). Mismatch repair (MMR) is a second fidelity system that
can correct replication errors which escape proofreading.
Characteristically, mutations that inactivate the exonuclease
activity of the replicative DNA polymerase combined with
those which inactivate MMR confer a very strong mutator
phenotype, far exceeding the sum of individual mutator effects.
Such synergistic hypermutability caused by a combination of
proofreading and MMR defects can also lead to accumulation
of lethal mutations sufficient to block propagation of a double-
mutant strain (31, 35).
Another synergistic interaction between exonuclease defi-
ciency in Pol  and mutations in RAD27, which encodes 5-flap
endonuclease FEN1, highlights the role for the Pol -Exo in
creating or maintaining a ligatable nick during Okazaki frag-
ment maturation. These two genetic defects are often synthetic
lethal (15, 25). In vivo evidence that Pol -Exo supplements
FEN1 in Okazaki maturation was obtained with viable double
mutants that that involved a rad27-p allele with a partial defect.
These mutants exhibited hyperrecombination and an unusual
pattern of hypermutability. The most frequent class of muta-
tions were extended duplications (up to 100 bp) flanked by
short direct repeats (4 to 10 bp) (24). Such mutations are
usually observed when the removal of 5-flaps generated by
DNA polymerase displacement between Okazaki fragments is
impaired (43). In agreement with the proposed defect in Oka-
zaki maturation, biochemical experiments have demonstrated
that strand displacement by the Exo-deficient Pol  is increased
to such an extent that full activity of FEN1 was required in
order to create a ligatable nick (22).
An additional mutation avoidance function of Pol -Exo that
is distinct from proofreading has been suggested based upon
the strong mutator synergy with mutations in EXO1 (45). Ex-
onuclease I (Exo1) was discovered in yeast as a 533 double-
* Corresponding author. Mailing address for D. A. Gordenin (for
genetic analysis): National Institute of Environmental Health Sciences,
D3-01, 101 TW Alexander Dr., P.O. Box 12233, Research Triangle
Park, NC 27709. Phone: (919) 541-5190. Fax: (919) 541-7593.
gordenin@niehs.nih.gov. Mailing address for Peter M. J. Burgers (for
biochemical analysis): Department of Biochemistry and Molecular
Biophysics, Washington University School of Medicine, Box 8231, 660
South Euclid, Saint Louis, MO 63110. Phone: (314) 362-3872. Fax:
(314) 362-7183. E-mail: burgers@biochem.wustl.edu
† Y.H.J., P.G., P.M.B., and D.A.G. contributed equally to this study.
‡ Present address: Nicholas School of Environment and Earth Sci-
ences, Duke University, Durham, NC 27708.
§ Present address: Department of Biochemistry, Duke University,
Durham, NC 27708.
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stranded DNA (dsDNA)-exonuclease (12, 41, 42). However,
its human homolog is capable of supporting both 5 and 3
excision during MMR in extracts and in a reconstituted system
(11, 16, 17). Exo1 has been implicated in double-strand break
repair and recombination, telomere maintenance, Okazaki
fragment maturation, and in MMR (reviewed in reference 48).
Exo1 physically interacts with eukaryotic MutS and MutL com-
plexes and, based on genetic data, was also proposed to play
structural role in MMR (1, 2, 47). In the yeast Saccharomyces
cerevisiae, mutator defects caused by deletion of EXO1 or by
mutations inactivating its exonuclease are much milder than
those due to elimination of mismatch recognition. Weak mu-
tator effects of Exo1 deficiency in yeast depend in part on Pol
 lesion bypass polymerase as determined from epistatic inter-
actions with rev3 (47, 49). It was suggested that Exo1 partici-
pates in an MMR-independent mutation avoidance pathway as
well as in mismatch removal during MMR (48). By analogy
with Escherichia coli, it was suggested that mismatch removal
in eukaryotic MMR could be accomplished by several redun-
dant nucleases, including Exo1 (42). While a weak mutator on
its own, exo1 is a very strong mutator in double-mutant yeast
strains that also lack the exonuclease activity of either Pol  or
Pol ε (45). Hypermutability in an exo1 pol3-01 (lacking the
exonuclease activity of Pol ) double mutant is comparable to
the extreme hypermutability observed in pol3-01 pms1 or
pol3-01 msh2 double mutants. This hypermutability could only
be measured in homozygous diploid strains because the hap-
loid double mutants were inviable, presumably due to error
catastrophe. These results led us to hypothesize that Pol -Exo
could be one of the redundant exonucleases that function in
MMR. The observed hypermutability of pol3-01 exo1 double
mutants is explained by their deficiency in both proofreading
and MMR, because Pol -Exo functions in proofreading,
whereas both Exo1 and Pol -Exo participate in MMR. For the
purpose of this paper, we will assume that the function of Pol
-Exo in the Exo1-dependent mutation avoidance pathway is
through its participation in MMR. However, the less likely
possibility of an unknown mutation avoidance system with a
similar strong mutator effect as MMR cannot be excluded.
Pol  is central to DNA replication in all eukaryotes. It
carries out its polymerization functions in a complex with
PCNA (for recent reviews, see references 21 and 29). How-
ever, it is not clear whether the exonuclease can also function
as a separate activity in vivo or whether all biological functions
are linked to Pol  in the replicative complex. Structural stud-
ies of smaller proofreading DNA polymerases have shown that
the polymerase and exonuclease active sites are localized in
separate domains. The closest structural model for Pol  is that
of the bacteriophage RB69 DNA polymerase, which is very
similar to the phage T4 polymerase. In this structure, the two
active sites are separated by about 40 Å (13). Translocation of
the nascent 3 end from the polymerase to the exonuclease
active site within the same enzyme molecule requires strand
separation of 2 to 3 bp. Upon misinsertion of a base, translo-
cation of the mismatched primer terminus from the polymer-
ase to the exonuclease domain is as important for efficient
proofreading as the catalytic exonuclease activity (9, 30) (Fig.
1). Based on these results, it appears that proofreading would
be most efficient if performed intramolecularly (i.e., by the
same DNA polymerase molecule that introduced the error)
rather than intermolecularly (i.e., by the exonuclease active site
of a separate DNA polymerase molecule).
However, any conclusion about the mode of action in vivo
cannot be determined just from structural predictions and in
vitro efficiency. Is has been suggested that cellular mutation
avoidance, especially in eukaryotes, can be accomplished
through intermolecular activities (reviewed in reference 38).
For example, during lagging strand synthesis, Pol  must dis-
sociate from DNA after ligation of adjacent Okazaki frag-
ments; therefore, some Pol  molecules in the vicinity of rep-
lication fork may not be associated with the nascent 3 end. As
a result, the exonuclease activity of Pol  molecules not in-
cluded in the replication complex could participate in proof-
reading and other biological functions of the exonuclease. Fur-
thermore, there are several other 335 exonucleases in the
cell which may be able to remove 3 nucleotides and substitute
for Pol  exonuclease in its mutation avoidance functions.
Genetic studies with yeast double mutants have suggested that
errors generated by Pol  could be proofread by the exonucle-
ase activity of Pol ε (32, 33); however, these data could also be
explained by the exonucleases of Pol  and Pol ε having mu-
tation avoidance functions distinct from proofreading (45).
Evidence for intramolecular proofreading occurring in vivo
has only been obtained for T4 DNA polymerase. A mutant
form of this polymerase compromised in strand separation was
also affected in translocation from the polymerase to the exo-
nuclease active site (34). Such mutants are considered to have
a defect in “switching” (Fig. 1). Based on their mutator phe-
notype in vivo, it was concluded that switching is important for
proofreading in T4, and therefore it is performed by the poly-
merase molecule that synthesizes the DNA strand. Thus,
switching mutants appear to be a good tool for resolving the
question about the in vivo mode of action for the exonuclease
in a DNA polymerase. Until now it has not been clear how the
335 exonuclease of Pol  functions in relation to its replica-
tion functions within cells. Attempts to isolate switching mu-
tants in yeast Pol  by sequence alignment with T4 Pol did not
identify any mutants with a significant mutator effect (19). In
this paper, we report the identification and characterization of
yeast Pol  mutants that are defective in switching of the
nascent primer terminus between the polymerase and exonu-
clease sites. These mutants have enabled us to establish that
Pol  proofreading requires the wild-type capacity for switch-
FIG. 1. Proofreading of incorporation errors requires both domain
switching and exonuclease activity. Upon misincorporation, DNA Pol
elongation is inhibited. Switching of the nascent 3 end from Pol to the
Exo domain (step 1) followed by exonuclease cleavage (step 2) and by
switching back to Pol domain (step 3) leads to reestablishment of
proper elongation substrate.
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ing. Switching is also essential for the Pol  exonuclease func-
tion in MMR and Okazaki fragment maturation. We conclude
that all three functions of Pol  exonuclease are performed
intramolecularly, i.e., within the replicating holoenzyme.
MATERIALS AND METHODS
Yeast strains and plasmids. All strains were isogenic to E134 (MAT lys2-A14
ade5-1 his7-2 leu2-3,112 trp1-289 ura3-52) (23, 46). pol3 mutations were made
with site-directed mutagenesis and introduced into the yeast genome via two-step
gene replacement as described previously (24). All mutations were designed to
change a restriction site which allowed genotyping by combination of PCR and
restriction digestion. Sequences of mutant plasmids and oligonucleotides are
available upon request. pBL304 contained the POL3 gene (as a 3.75-kb MluI-
HindIII fragment) inserted into the SalI-HindIII sites of YCp50 (pBR322 URA3
CEN4 ARS1).
Yeast genetic methods. Methods for modifying yeast strains, measuring mu-
tation rates, and sequencing can1 mutant alleles were performed as described in
references 15 and 23. All conclusions about differences in mutation rates were
made based on nonoverlapping 95% confidence intervals calculated for each
mutation rate (not shown in the experimental tables; data available upon re-
quest). In order to assess the viability of pol3 mutations in combination with null
alleles of DNA metabolic genes, double mutants were obtained from single pol3
mutants in the presence of plasmid pBL304 carrying the wild-type POL3 gene
and a URA3 marker. Deletions were generated by KanMX4 replacement cas-
settes as described previously (23). pBL304 could be readily lost from pol3
mutants, as determined by growth of plasmid-less cells on medium with 5-fluoro-
orotic acid (5-FOA). Double mutants that were unable to grow on 5-FOA were
considered inviable in the absence of wild-type POL3. Inability to lose pBL304
was confirmed by assessing plasmid loss after growing strains under nonselective
conditions (yeast extract, 10 g/liter, peptone, 20 g/liter; glucose, 20 g/liter, ade-
nine, 10 mg/liter [YPDA]). Following two passages of replica plating under
nonselective conditions, strains were plated at low density onto YPDA to allow
growth of colonies that lost the plasmid as well as colonies containing the
plasmid. After 4 days of growth, about 1,000 individual colonies were replica
plated on complete medium and on the medium without uracil. In the strains
that were unable to lose the plasmid based on the 5-FOA assay, only one or two
colonies were able to grow without uracil. Single mutants and double mutants
that were determined as viable in the 5-FOA selective assay produced 10 to 50%
colonies without pBL304 (POL3) plasmid in the nonselective medium assay.
Plasmid-based screen for mutator mutations in Exo III motif of the yeast
POL3. The collection of putative mutator mutations was initially obtained by
oligonucleotide-directed mutagenesis of the bases corresponding to amino acids
513 to 528 within the Exo III motif in the yeast POL3 gene contained in the
pBL304 plasmid. Mutagenic oligonucleotide mix (Bioserve Biotechnologies) was
designed to contain 94% of a wild-type base and 2% of each of 3 possible altered
bases in every position corresponding to the first and second nucleotides of
mutagenized codons. The mutagenized plasmid mix was transformed into a
pol3-t mutant strain containing a temperature-sensitive allele of POL3. Trans-
formants were grown at 37°C, where the genomic pol3-t allele is not functional,
and replica plated to selective media that enabled the detection of mutations
within the mutation reporters, lys2-A14, his7-2, and can1. (The screening capacity
of reporters is discussed in the Results section.) In control experiments with the
pBL304 plasmid containing the previously characterized Exo-deficient allele
pol3-01, we observed clear mutator phenotypes after growth at 37°C. The use of
a yeast strain with the temperature-sensitive allele pol3-t allowed better detection
of mutator mutations having exonuclease-related defects, since they are usually
temperature resistant (24). The mutagenized region of the POL3 gene was
sequenced in the isolated mutator strains. Forty-one mutator strains isolated
from 2,982 screened transformants contained mutations in residues V515, Y516,
C517, K519, D520, Y522, L523, P524, L525, and M528. The total number of
different mutations was 52, since 11 strains contained double changes.
Enzymes. Pol -L523H was purified from overproduction strain YH1178
(pol3-L523H pep4::KanMX strain isogenic to E134) carrying pBL336-LH (2m
ori TRP1 GAL1-pol3-L523H), and pBL341 (2m ori URA3 GAL1-POL31
GAL10-POL32) (7). The L523H mutation was introduced into plasmid pBL336
(containing wild-type POL3) by gap repair in strain YH1178, analogous to the
method described previously for other mutants (22). The resulting plasmid allele
was verified by PCR amplification and sequencing of the relevant region of the
POL3 gene. Pol -L523S and Pol -L523D were prepared similarly through gap
repair and overproduction in strains YH1170 (as YH1178, but pol3-L523S) and
YH1166 (as YH1178, but pol3-L523D), respectively. The purification of Pol -01
and Pol -5DV has been described previously (22). Replication factor C (RFC),
replication protein A (RPA), and PCNA were purified as described previously
(4, 18, 20).
Replication assays. Standard 30-l assay mixtures contained 20 mM Tris-HCl,
pH 7.8, 1 mM dithiothreitol (DTT), 100-g/ml bovine serum albumin, 8 mM
MgAc2, 1 mM ATP, 80 M each of the nonradioactive deoxynucleoside triphos-
phates (dNTPs) and 20 M [-32P]dNTP, 100 mM NaCl, 50 fmol of singly
primed single-stranded M13mp18 DNA, 10 pmol of RPA, 100 fmol of RFC, 250
fmol of PCNA, and the indicated levels of wild-type or mutant Pol . In general,
the DNA was preincubated with RPA, PCNA, and RFC for 1 min at 30°C and
the reaction was started by adding Pol . Incubations were at 30°C. Reaction
products were analyzed by electrophoresis on a 1% agarose gel or by acid
precipitation followed by filtration over a glass fiber filter and scintillation count-
ing. The gels were dried and analyzed on a phosphorimager. Quantitation was
carried out with ImageQuant software. The images in the figures were contrast
enhanced for visualization.
Nuclease assays. The 50-l pUC19 nuclease assay mixture contained 20 mM
Tris-HCl, pH 7.8, 1 mM DTT, 100-g/ml bovine serum albumin, 8 mM MgAc2,
1 mM spermidine-HCl, 50 fmol of pUC19 DNA (which had been linearized with
EcoRI, followed by filling in of the overhanging ends with dATP and [3H]dTTP),
and wild-type or mutant Pol . After 4 min at 30°C, the reactions were stopped
by addition of 100 l of 25 mM EDTA, 25 mM sodium pyrophosphate, and
50-g/ml carrier DNA, followed by 125 l of 10% trichloroacetic acid. After 10
min on ice, the tubes were spun in a microcentrifuge for 10 min. Two hundred
microliters of the supernatant was added to a water-miscible scintillation fluid
and counted in a liquid scintillation counter.
The 113-nucleotide (nt) 5- and 3-biotinylated template Bio-V6 (Bio-5-AG
TTGGGTTGGTTTTGTTTGGTGGAACCT25CTCCCTTCTTCTCCTCCCTC
TCCCTTCCCT31-Bio) was prepared by hybridizing two half-oligonucleotides to
a bridging primer followed by ligation with T4 DNA ligase and purification by
preparative urea-polyacrylamide gel electrophoresis (PAGE). The template was
primed with primer COKA13A (5-32P-AGGGAAGGGAGAGGGAGGAGAA
GAAGA) forming a single 3-terminal C-A mismatch with the Bio-V6 template.
All oligonucleotides were obtained from Integrated DNA Technologies and
purified by polyacrylamide electrophoresis or high-performance liquid chroma-
tography before use. After hybridization, a twofold molar excess of streptavidin
was added. The nuclease assay was carried out in a 30-l reaction mixture
containing 20 mM Tris-HCl, pH 7.8, 1 mM DTT, 100-g/ml bovine serum
albumin, 8 mM MgAc2, 100 mM NaCl, 150 fmol of template primer, 500 fmol of
RPA, 400 fmol of RFC, and 750 fmol of PCNA. The reaction mixture was
incubated at 30°C for 1 min, and the reaction was started by addition of 600 fmol
of Pol . Aliquots (8 l) were withdrawn at the indicated times and analyzed by
12% denaturing PAGE. After drying of the gel, radioactivity was quantitated by
phosphorimaging. Rates of hydrolysis of the 3-terminal mismatched nucleotide
were calculated from the 30-s time points with a pseudo-first-order kinetic
model.
RESULTS
Genetic and biochemical defects caused by pol3-L523X mu-
tations. Mutations modifying L523 were recovered repeatedly
in our plasmid-based screen for strong mutator mutations in
the Exo III motif of yeast POL3, the catalytic subunit of Pol 
(Materials and Methods). While the L523 is invariant in Pol 
sequences (not shown), this residue is not conserved in several
other DNA polymerases (Fig. 2). This contrasts with the in-
variant aspartate residue (D520 in S. cerevisiae Pol ) required
for exonuclease catalysis in all B-class polymerases, including
yeast Pol  (24, 39). Based on this, we reasoned that L523 is
unlikely to be directly involved in catalysis but may well be
important for a specific Pol -related function. To further
understand why amino acid replacements at position 523 lead
to a mutator phenotype, we created several mutations chang-
ing L523 at the chromosomal POL3 gene. In total, seven dif-
ferent changes were made: L523R, L523Q, and L523V, which
were isolated in the initial plasmid-borne screen, as well as
changes to charged residues L523D and L523H and changes to
smaller residues L523A and L523S.
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The mutator activity of the pol3 alleles was assessed with
three reporters: lys2-A14 reversion (1 frameshifts in an A14
run), his7-2 reversion (1 frameshifts in an A7 run), and for-
ward mutations in the CAN1 gene. The lys2-A14 reversion
assay is very sensitive to inactivation of MMR because premu-
tation intermediates arising during replication escape proof-
reading, thus leaving the burden of mutation prevention to
MMR (45, 46). The his7-2 reversion assay and the can1 for-
ward mutation assay are sensitive to both proofreading and
MMR defects (31, 37, 45).
In addition to pol3-L523X, we measured changes in muta-
tion rates caused by two previously described alleles, pol3-01
and pol3-5DV, that completely inactivate the exonuclease.
pol3-01 (D321A, E323A) is a double mutation in the Exo I
motif (31), and pol3-5DV (D520V) is a mutation in the Exo III
motif (24). The L523 mutations caused mutator phenotypes
(Table 1) that in some cases exceeded the mutator effects of
the two previously characterized exonuclease-defective pol3
mutants.
Three L523X mutant forms of Pol  were overexpressed and
purified from yeast. These mutants were chosen because they
showed mutator phenotypes that were strong (L523D), me-
dium (L523S), and marginal (L523H). Their DNA polymerase
activities were comparable to that of the wild type (Fig. 3A).
This is consistent with structural studies which indicate that the
polymerase and exonuclease domains are autonomous. How-
ever, unlike the catalytic mutants (Pol -01 and Pol -5DV),
the L523 mutants retained partial to full exonuclease activity,
when measured as hydrolysis of the 3 end of linear blunt-
ended dsDNA (Fig. 3B). In order to measure exonuclease
activity toward a mismatch that would be encountered by Pol 
during processive DNA replication: i.e., in a complex with
PCNA, we used an oligonucleotide-based template-primer as-
say system. The substrate contained biotin-streptavidin blocks
to prevent dissociation of PCNA by sliding off the DNA (3).
PCNA was loaded by RFC onto the RPA-coated template
primer prior to addition of the polymerase. Rates of hydrolysis
of the 3-terminal mismatched nucleotide were measured (Fig.
3C). Unlike the catalytic mutants, the L523 mutant enzymes
retained considerable exonuclease activity: 100% (86 to 111%)
with L523H, 68% (59 to 72%) with L523S, and 10% (7 to 16%)
with L523D (ranges of values obtained in three independent
experiments). After removal of the terminal mismatch, all en-
zymes continued to degrade efficiently into the dsDNA region,
with the exception of Pol -L523D. Because of the low catalytic
activity of Pol -L523D, both the activity on dsDNA and its
processivity are expected to be seriously impaired, and this was
indeed observed (Fig. 3C). In the absence of PCNA, the nu-
clease activity of each form of Pol  decreased to 5 to 10% of
the activity demonstrated in the presence of PCNA (data not
shown).
One possible explanation for a mutator phenotype with a
DNA polymerase that has robust exonuclease activity is that
the enzyme fails to translocate the mismatched primer termi-
nus from the polymerase to the exonuclease domain. Exonu-
clease-proficient mutator mutants have been identified for E.
coli DNA polymerase I and for the T4 DNA Pol (28, 30). In a
biochemical analysis, these mutants showed altered partition-
ing of the DNA between the polymerase and exonuclease
active sites, and it has been suggested that these mutants are
defective in switching upon misincorporation. In this study, we
developed a biochemical assay to assess defects in switching
upon misincoporation by Pol . The premise of the assay is that
DNA synthesis by either an exonuclease-defective or a switch-
ing-defective enzyme will be inhibited when misincorporation
occurs. Under conditions of precursor nucleotide imbalance,
misincorporation by the polymerase is increased. For the wild-
type enzyme, this is not a problem because rapid translocation
of the mismatch to the exonuclease domain, i.e., switching,
followed by excision allows the polymerase to resume synthe-
sis. However, because the polymerase does not readily elon-
gate from mismatches, overall inhibition of DNA synthesis by
either an exonuclease-defective or switching-defective Pol  is
expected under these conditions (Fig. 1). This inhibition assay
will only work for a switching-defective polymerase if proof-
reading in trans is either inefficient or does not occur at all.
Proofreading in trans involves dissociation of the misincorpo-
rating enzyme, followed by binding of the mismatch to another
enzyme molecule in its exonuclease site. After subsequent ex-
cision of the mismatch, perhaps another cycle of dissociation
and rebinding allows resumption of polymerization (Fig. 1).
Replication of the 7.3-kb-long singly primed single stranded
M13mp18 DNA by Pol  holoenzyme was monitored by dena-
turing agarose gel electrophoresis (Fig. 4). All five DNA poly-
merases tested showed comparable activity when the concen-
FIG. 2. Alignment of Exo III motifs in different DNA polymerases.
Invariant amino acids in the alignment of all 26 Pol  from the Gen-
Bank (not shown) are underlined and boldface. Arrows point to resi-
dues mutated in the current study to create pol3-5DV and pol3-L523X
alleles. Ec, E. coli; Sc, S. cerevisiae; HSV, herpes simplex virus.
TABLE 1. Mutation rates in pol3 mutants
Allele
Mutation ratea
lys2-A14 his7-2 can1
POL3 1 1 1
pol3-01 9.7 78 19
pol3-5DV 4.9 16 12
pol3-L523H 1.2 3.1 1.5
pol3-L523V 2.6 3.7 5.1
pol3-L523Q 3.7 13 8.4
pol3-L523A 6.4 14 15
pol3-L523S 7.9 28 20
pol3-L523R 32 37 90
pol3-L523D 72 178 113
a Rates are relative to wild type: lys2-A14 reversion, 29 	 108; his7-2 rever-
sion, 1.2 	 108; can1 forward mutation, 41 	 108.
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tration of the radioactive dATP was 5 M and each of the
other dNTPs was 40 M (Fig. 4B). Selective increase of dGTP
to 2 mM is expected to increase misinsertion as the dGTP/
dATP ratio is now 400. Under this condition of imbalance, only
minor inhibition of replication by wild-type Pol  was observed.
Some inhibition of overall DNA synthesis is expected even for
the wild-type enzyme as it is forced through multiple, unpro-
ductive cycles of misincorporation followed by proofreading.
However, consistent with the requirement for removal of mis-
incorporated bases, replication by Pol -01 and Pol -5DV was
almost completely inhibited (Fig. 4C and D). Replication by
Pol -L523D was also strongly inhibited, while that by the
L523S and L523H enzymes showed intermediate phenotypes.
In order to obtain a quantitative estimate of the inhibition, we
measured replication activity as a function of dGTP concen-
tration and determined the concentration of dGTP required to
obtain 50% inhibition. This was achieved at 0.25 to 0.35 mM
dGTP for the two exonuclease-deficient forms and for Pol
-L523D; at 1.5 mM and 3 mM for the Pol -L523S and
-L523H mutants, respectively; and at an estimated 
10 mM
dGTP for the wild type (Fig. 4D).
Assuming that the fidelity of nucleotide insertion by Pol
-L523H or Pol -L523S is not affected by the mutation in the
exonuclease domain (see Discussion), the most straightfor-
ward explanation for the observed inhibition is that these two
enzymes, which exhibit full or nearly full wild-type exonuclease
catalytic activity, have a reduced capacity to switch the nascent
3 end between the Pol and Exo sites. Therefore, we desig-
nated them as switching mutants. Importantly, the severity of
the proposed biochemical defect in switching correlates well
with the observed mutator effect caused by the pol3-L523D,
-L523S, and -L523H mutations in vivo (Table 1) (data pre-
sented below). We propose that in the other pol3-L523X mu-
tants, a defect in switching may also contribute to their biolog-
ical defects.
pol3-L523X mutations exhibit synthetic lethality with msh2,
exo1, and rad27 defects. Synthetic lethality and/or synergistic
hypermutability caused by combining exonuclease-defective
pol3 mutations with mutations causing a defect in mismatch
recognition (e.g., msh2), 5-flap removal (rad27), and mis-
match removal (exo1) highlight the biological roles of the
335 exonuclease in proofreading, Okazaki fragment matu-
ration, and MMR, respectively (see the introduction). We
asked whether the in vivo functions that depend on the exo-
nuclease activity of Pol  would also be impaired in the switch-
ing mutants.
Double mutants were created in the presence of a plasmid
carrying wild-type POL3, and the viability of the double mu-
tants was assessed in a plasmid-loss assay as described in Ma-
terials and Methods. Since the transformation frequency of the
pol3-L523R strain with the rad27::KanMX4 deletion cassette
was very low and transformants grew slowly, lethality of the
pol3-L523R rad27 double mutant was established by tetrad
analysis (not shown). Similar to the catalytic pol3-01 and pol3-
5DV mutants, most switching mutants were inviable in combi-
nation with msh2, exo1, or rad27 (Table 2). Viable com-
binations with exo1 and msh2 were formed only with the
pol3-L523V and pol3-L523H alleles, which had very weak mu-
tator activities on their own (Table 1). Interestingly, all pol3-
L523X mutations, including the weakest mutator alleles, were
synthetically lethal with rad27. We sought to determine if at
least some of them would be viable in combination with the
more subtle rad27-p mutation that decreases the affinity of
FEN1 for PCNA (15). Diploids were generated that were het-
erozygous for rad27-p and either pol3-L523H (weakest defect)
or pol3-L523S (medium defect). All spores in 12 dissected
tetrads from pol3-L523H/POL3 RAD27/rad27-p diploids were
viable. Genotyping by PCR and restriction digestion (not
shown) identified 12 pol3-L523H rad27-p viable double mu-
tants among the meiotic progeny. However, pol3-L523S
rad27-p double mutants were inviable. There were 24% dead
spores in the tetrads of the pol3-L523S/POL3 RAD27/rad27-p
diploid, and there were no double mutants among 36 meiotic
segregants genotyped (P  104).
Switching mutation pol3-L523S and catalytic mutation pol3-
5DV show similar mutator effects when combined with MMR
defects. Homozygous diploid double mutants that combine the
catalytic exonuclease defect in pol3-01 with msh2 (or pms1) or
FIG. 3. Polymerase and exonuclease activities of the wild-type and mutant DNA polymerases. Singly primed SS M13mp18 DNA replication
assays were performed (A) and exonuclease activities on terminally labeled blunt-end double-stranded (DS) pUC19 were determined (B) as
described in Materials and Methods. The replication assays measured processive polymerase activity, with PCNA present, whereas the exonuclease
assay on blunt-end DNA were carried out without PCNA. (C) Exonuclease activities were measured on an oligonucleotide template primer
containing a C-A mismatch in the presence of RPA and PCNA, loaded by RFC. Strep-Bio, streptavidin-biotin. The streptavidin blocks prevent
dissociation of PCNA by sliding off the DNA. See Materials and Methods for further details. In the absence of PCNA, the nuclease activity of each
form of Pol  was severely decreased to 5 to 10% (data not shown).
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with exo1 are viable, unlike the corresponding haploid double-
mutant strains. This rescue of viability has been attributed to
the recessive nature of the majority of lethal genetic changes
that lead to error catastrophe in haploid double mutants. The
hypermutability of diploid double mutants is due to the elim-
ination of most if not all of the mutation avoidance activity that
could compensate for the exonuclease defect in pol3-01. In
other words, mutator defects in pol3 mutants can be masked to
various degrees by the MMR machinery (31, 45). Therefore,
measuring mutation rates in diploids of double mutants of
msh2 or exo1 with the pol3 alleles (including pol3-L523X) al-
lows a better evaluation of the relative severity of the pol3
defects in vivo than can be obtained by measurements in the
single pol3 mutants. Specifically, the mutator effect of a pol3
allele in a double mutant with msh2 allows us to evaluate
defect of proofreading caused by the pol3 mutation, whereas
the mutator effect in pol3 exo1 addresses the defect caused by
the pol3 mutation in a nuclease-related putative MMR func-
tion.
Diploid double mutants were created by expressing the HO-
endonuclease as described previously (44) in pol3 msh2 or pol3
exo1 double-mutant haploids, in which the pol3 defect was
complemented by wild-type POL3 in plasmid pBL304. Dip-
loids were propagated on YPDA in order to allow the loss of
the POL3 and HO plasmids. Based on the high frequency of
loss of the POL3-containing plasmid (not shown), the diploid
double mutants are viable.
Mutator synergy (excess of mutation rate in a double mutant
over the sum of rates in single mutants) was observed with both
catalytic and switching mutants for both reporters tested (Ta-
ble 3). (Note that can1 mutation rates could not be measured
in the diploids because canavanine resistance is recessive.)
Both pol3-L523S and pol3-5DV double mutants with either
msh2 or exo1 showed a synergistic increase in his7-2 rever-
sion, 15 to 60 times more than would be expected for additive
interaction. Thus, the catalytically defective mutation pol3-
5DV and the switching-defective mutation pol3-L523S impair
both the proofreading and MMR functions of the exonuclease
in vivo. Importantly, for each type of double mutant, with
exo1 or with msh2, the rates of his7-2 reversion were similar
for both pol3 mutations, suggesting that their in vivo functions
FIG. 4. Nucleotide imbalance inhibits replication in switching mu-
tants of Pol . (A) Scheme of the assay. (B) Replication with 40 M
dGTP. Wt, wild type. (C) Replication with 2 mM dGTP. Results with
Pol -5DV (not shown) were indistinguishable from those with Pol
-01 (see also panel D). (D) Replication with various concentrations of
dGTP (from 40 M to 3 mM). Standard replication reaction mixtures
as described in Materials and Methods were modified to contain 40
M dCTP, 40 M dTTP, 5 M [-32P]dATP, and the indicated con-
centrations of dGTP. Reactions in panels B and C were stopped after
1, 2, and 4 min of incubation and analyzed on a 1% alkaline agarose
gel. Reactions in panel D were stopped after 4 min of incubation, and
acid-precipitable radioactivity was determined. The activity at 40 M
dGTP was set at 100%.
TABLE 2. Synthetic lethality of pol3 mutations
Allele
Viability of double mutantsa
exo1 msh2 rad27 rad27-p
pol3-01 b b c c
pol3-5DV   c c
pol3-L523D    NDd
pol3-L523R   e ND
pol3-L523S    e
pol3-L523A    ND
pol3-L523Q    ND
pol3-L523V    ND
pol3-L523H    e
a Viability was assessed by plasmid loss, unless otherwise indicated. , viable;
, inviable.
b Determined in reference 44.
c Determined in reference 24.
d ND, not determined.
e Interactions were assessed by tetrad analysis.
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are impaired to the same extent by either the catalytic or the
switching mutations. There was also strong synergy for rever-
sion of lys2-A14 in pol3 exo1 double mutants (460 to 620 times
more than expected for additive interaction), supporting the
conclusion that both types of pol3 defects compromise MMR.
As shown earlier, most errors in microsatellites, such as
those leading to mutations in the lys2-A14 reporter, escape
correction by the proofreading exonuclease (26, 40, 44, 46). In
agreement with these observations, the mutator synergy be-
tween the pol3 mutations and msh2 was modest: only two- to
eightfold over the rate expected for additivity.
Synergistic interactions of weak pol3-L523X mutators with
msh2, exo1, and rad27 defects. Since haploid strains combining
pol3-L523V or pol3-L523H with msh2, or exo1 as well as
pol3-L523H with rad27-p, were viable (Table 2), we examined
mutability in these double mutants (Table 4). Both msh2 and
exo1 showed significant synergy with the pol3 mutants in a
his7-2 reversion or can1 forward mutation assay. There was
also significant synergy in the pol3 double mutants with exo1
for lys2-A14 reversions. Based on comparison of 95% confi-
dence intervals (not shown), the pol3-L523X msh2 double
mutants showed either no synergy or only marginal synergy in
the lys2-A14 reversion assay, reflecting the escape of frameshift
mutations in this target from proofreading (see the previous
section). We conclude that both weak pol3-L523X mutators
are defective in proofreading and MMR in vivo. However,
since the mutation rates were lower than in the corresponding
double mutants with pol3-L523S and pol3-5DV, the proofread-
ing and MMR defects in pol3-L523H and -L523V are partial
(Table 4).
The haploid double mutant pol3-L523H rad27-p showed a
synergistic increase in mutation rate for all three reporters
(Table 5). In order to assess whether there was an increase in
the rate of extended duplications that are diagnostic of a defect
in Okazaki fragment maturation (43), we compared the muta-
tion spectrum of forward can1 mutations in the pol3-L523H
rad27-p double mutant with mutation spectra in single-mutant
and wild-type strains (Tables 5 and 6). Importantly, the syner-
gistic increase in can1 mutation rates can be accounted for by
extended duplications flanked by short direct repeats. The
absolute rate of duplications in this double mutant (1.7 	
105) is very close to the rate of duplications in a pol3-5DV
rad27-p double mutant (1.8 	 105) involving a Pol  without
Exo activity. We conclude that the switching defect in the
pol3-L523H mutant impedes Okazaki maturation to an extent
comparable with that in the catalytically null pol3-5DV mutant.
DISCUSSION
Previous genetic studies have established that the exonucle-
ase activity of Pol  participates in three distinct fidelity mech-
anisms, i.e., proofreading, maturation of Okazaki fragments,
and EXO1-dependent mutation avoidance, which is proposed
to involve degradation of the mismatched DNA during MMR
(see Fig. 5 and the introduction). Below, we summarize the
evidence suggesting that switching between the polymerase
and exonuclease domains is also required in these three path-
ways and discuss the implications of this conclusion.
Defects in partitioning of substrate DNA between polymer-
ase and exonuclease sites have been documented for several
TABLE 3. Mutation rates in single- and double-mutant
diploid strains
Genotype
Relative mutation ratea
lys2-A14 his7-2
POL3 1 1
exo1/exo1 24 14
msh2/msh2 6,400 65
pol3-5DV/pol3-5DV 39 95
pol3-5DV/pol3-5DV
exo1/exo1
39,300 (63) 4,600 (109)
pol3-5DV/pol3-5DV
msh2/msh2
50,400 (6,439) 9,300 (160)
pol3-L523S/pol3-L523S 19 240
pol3-L523S/pol3-L523S
exo1/exo1
15,300 (43) 3,800 (254)
pol3-L523S/pol3-L523S
msh2/msh2
14,600 (6,419) 7,900 (305)
a Rates are relative to wild type: lys2-A14 reversion, 36 	 108; his7-2 rever-
sion, 1.1 	 108. Relative rates expected for an additive effect of two mutators
in the double mutant are shown in parentheses.
TABLE 4. Mutation rates in haploid strains carrying
pol3-L523X, exo1, and msh2
Genotype
Mutation ratea
lys2-A14 his7-2 can1
POL3 1 1 1
exo1 33 2.0 6.0
msh2 7,200 46 16
pol3-L523V 2.6 3.7 5.1
exo1 pol3-L523V 690 (36) 810 (5.7) 130 (11)
msh2 pol3-L523V 16,000 (7,200) 7,400 (50) 68 (21)
pol3-L523H 1.2 3.1 1.5
exo1 pol3-L523H 290 (34) 210 (5) 39 (7)
msh2 pol3-L523H 19,000 (7,200) 2,000 (49) 500 (18)
a Rates are relative to wild type (absolute rates for wild type are given in the
footnotes to Table 1). Relative rates expected for an additive effect of two
mutators in the double mutant are shown in parentheses.
TABLE 5. Mutation rates in haploid strains carrying
pol3-L523H and rad27-pa
Genotype
(no. of isolates)b
Mutation rate can1
lys2-A14 his7-2 Mutationrate
Duplication
ratec
Wild type (4) 1 1 1 0 (0/20)
pol3-L523H (4) 1.4 2.5 2.5 0 (0/27)
rad27-p (4) 2.1 2.3 2.6 1.3 (9/18)
pol3-L523H
rad27-p (8)
9.7 [3.5]d 33 [4.8] 33 [5.1] 28 (21/25) [1.3]
a Rates are relative to the wild type: lys2-A14 reversion, 30 	 108; his7-2
reversion, 1.5 	 108; can1 forward mutation rate, 61 	 108.
b Isolates from tetrad dissection of the double heterozygous diploid pol3-
L523H/POL3 rad27-p/RAD27.
c Rates of extended duplications in CAN1 relative to the total rate of can1
mutations in the wild type were calculated based on the fraction of duplications
among all can1 mutants sequenced (numbers of duplications and the total num-
bers of sequenced can1 mutants are given in parentheses as the numerator and
denominator, respectively). The mutation spectra for the wild type and rad27-p
are taken from reference 24. Mutation spectra determined in this work are
presented in Table 6.
d Relative rates expected for an additive effect of two mutators in the double
mutant are shown in brackets.
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DNA polymerases (28, 30). The partitioning mutations in T4
DNA polymerase are of particular interest because this en-
zyme is closely related to Pol . Kinetic studies of a G255S
mutant in the exonuclease domain of the T4 enzyme have
shown that the mutant is defective for strand separation at the
primer terminus. This results in inhibition of translocation of
the 3 end of the nascent strand from the polymerase to the
exonuclease domain (30, 34). While this defect resulted in a
strong mutator phenotype in phage T4, the yeast pol3-G447S
mutation that was chosen based on sequence alignment gave
an antimutator phenotype for frameshifts in homopolymeric
runs (19). Our data indicate that amino acid L523 adjacent to
the conserved Exo III motif is important for switching in Pol .
Crystallographic studies of bacteriophage RB69 DNA poly-
merase, the closest structural homolog to Pol , show that the
polymerase and exonuclease activities reside in separable do-
mains with the active sites separated by about 40 Å (13).
Therefore, it was not surprising that the L523X mutants of Pol
 displayed normal polymerization activity. However, in two
different assay systems, Pol -L523H and Pol -L523S showed
wild-type or near-wild-type exonuclease activity (Fig. 3). In
order to reconcile the observed mutator phenotype of these
mutants with the presence of an intact exonuclease activity, we
investigated whether these mutants could be partially defective
in switching the 3 terminus between the polymerase and ex-
onuclease domains. In a DNA replication assay under condi-
tions of nucleotide precursor imbalance that enhance misin-
corporation, defects in either the exonuclease catalytic activity
or in switching of the mismatch primer terminus from the Pol
to Exo site would result in an overall inhibition of DNA syn-
thesis, as indeed was observed for all three L523 mutant en-
zymes. The most compelling argument for the importance of
the L523 residue in switching was obtained with Pol -L523D.
This enzyme was inhibited by dNTP imbalance to the same
TABLE 6. Spectrum of can1 mutationsa
Mutation type
Wild typeb pol3-L523H pol3-L523H rad27-p
Mutation
No. of
occurrences/
total (%)
Mutation
No. of
occurrences/
total (%)
Mutation
No. of
occurrences/
total (%)
Base substitution C3A 4/20 G3A 3/27 TT3CA 1/25
C3T 2/20 G3T 3/27 C3A 1/25
C3G 1/20 A3T 1/27 2/25 (8)
G3A 4/20 T3C 5/27
G3T 3/20 T3A 1/27
A3G 1/20 C3A 1/27
T3A 1/20 14/27 (52)
16/20 (80)
Frameshift T43T3 1/20 T63T7 3/27 G43G3 1/25
T33T2 1/20 T63T5 1/27 C13C0 1/25
2/20 (10) T53T4 1/27 2/25 (8)
T43T3 1/27
T33T2 1/27
C33C2 2/27
A23A1 1/27
A33A1 1/27
(AT)23(AT)1 1/27
12/27 (44)
Insertion/deletion 1324–1339 (16, 8) 1/20 (5) 887–893 (7, 4) 1/27 (4) I224–255 (32, 5) 1/25
I289–306 (18, 4) 1/25
I380–403 (24, 6) 1/25
I630–689 (60, 8) 2/25
I762–810 (49, 7) 2/25
I776–802 (27, 8) 1/25
I906–1049 (144, 7) 1/25
I1002–1019 (18, 6) 2/25
I1163–1183 (21, 5) 1/25
I1265–1333 (69, 5) 2/25
I1401–1424 (24, 6) 1/25
I1488–1520 (33, 5) 1/25
I1494–1552 (59, 6) 1/25
I1580–1617 (38, 6) 4/25
21/25 (84)
Complex TTCTC3CTCTCTG 1/20 (5) 0/27 (0) 0/25 (0)
a All designations are the same as those in reference 24. Nucleotide coordinates of the wild-type CAN1 gene are used with the A of the ATG as nt 1. Deletion
mutations are designated by x-y (a, b). Insertion mutations are designated by 1x-y (a, b). x and y are the nucleotide coordinates of the first and last nucleotides,
respectively, of the wild-type sequence that are deleted (x-y) or inserted (1x-y); a is the length of the deletion/insertion; and b is the length of the associated short direct
repeat sequence. ,repeat with a 1-nt mismatch.
b Data are from reference 24.
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degree as the exonuclease-deficient Pol -01 or Pol -5DV.
However, its exonuclease domain retains partial activity, and
therefore this inhibition cannot be attributed to the reduction
in exonuclease catalysis alone, indicating that this mutant is at
least partially defective in switching the mismatched 3 termi-
nus to the exonuclease domain (Fig. 4). The other L523 mu-
tants were inhibited to a lesser extent under conditions of
nucleotide precursor imbalance. As Pol -L523H showed wild-
type exonuclease activity, the observed inhibition can be attrib-
uted to a partial defect in switching. A similar argument for a
switching defect can be made for Pol -L523S, which was more
strongly inhibited than the L523H mutant under dNTP imbal-
ance, yet still exhibited near-wild-type exonuclease activity.
However, the interpretation of the exonuclease measurements
for Pol -L523S may be complicated by the likely bimodal
binding of the substrate to the enzyme. Pre-steady-state kinetic
studies of bacteriophage T4 DNA polymerase have shown that
even a mismatched template-primer DNA binds predomi-
nantly to the polymerase site rather than the exonuclease site
(5, 8). To observe catalytic activity, the DNA substrate either
has to switch to the exonuclease site or dissociate and rebind to
the exonuclease site. If the structurally related Pol  shows
similar binding properties, a mutation that inhibits switching
would also cause a decrease in the measured rate of exonucle-
ase activity, even though the microscopic rate of catalysis might
not be affected. Therefore, the observed lower exonuclease
activity for Pol -L523S may in part or in total be caused by a
switching defect in this mutant.
While all observations are consistent with a partial defect in
switching by the Pol -L523 mutants, the observed in vivo
mutator phenotype as well as the observed inhibition of in vitro
DNA replication under dNTP imbalance conditions can also
be explained if the mutant polymerases showed an increased
rate of misincorporation and/or frameshift misalignment com-
pared to the wild type. We consider this unlikely because
mutant L523X enzymes show wild-type levels of DNA poly-
merase activity and because, based on the analogies with RB69
DNA polymerase (see the introduction), the Pol and Exo ac-
tivities reside in separate domains. However, we cannot cur-
rently exclude the possibility that incorporation fidelity is neg-
atively affected through long-range perturbations in these
mutants. Even if this happens, it cannot explain the defects in
Okazaki maturation caused by L523X changes. Importantly, a
recent study of the activity of Pol  at a nick adds further
support to our proposed switching model. When a replicating
PCNA-Pol  complex reaches downstream dsDNA, it rapidly
turns over dNTP to dNMP at the nick position by repeated
cycles of extension followed by exonucleolytic degradation, a
process called “idling ” (14). The rate of idling is dependent on
the efficiency of forth and back switching between the Pol and
Exo domains. The rate of idling by Pol -L523H is only 32%
that of the wild type, that of the L523S mutant is only 10% of
that of the wild type, and that of the L523D mutant is only 1%
of that of the wild type, indicating that all three mutants show
defects in switching in an assay, which does not depend upon
misincorporation.
The three in vivo functions of Pol -Exo depend on efficient
switching between Pol and Exo sites. All pol3-L523X mutations
showed synthetic lethality and/or mutator synergy with msh2,
exo1, and rad27 mutations, highlighting the in vivo defects in
proofreading, MMR, and Okazaki fragment maturation, re-
spectively. All mutants have wild-type DNA polymerase activ-
ity but exhibit exonuclease-related defects (Fig. 3 and 4). Based
on a comparison of the in vitro switching and exonuclease
activity defects of the pol3-L523X mutants with their in vivo
defects, we concluded that the function of the nuclease in
proofreading, MMR, and Okazaki fragment maturation re-
quires efficient switching. This conclusion is most straightfor-
ward for the pol3-L523H mutant. In vitro Pol -L523H showed
wild-type exonuclease activity, while exhibiting a partial switch-
ing defect. Therefore the in vivo defects in proofreading,
MMR, and Okazaki fragment maturation, revealed as syner-
gistic hypermutability in combination with msh2, exo1, and
rad27-p (Tables 4 and 5), are likely to result from a defect in
switching. Similar arguments can be made for the pol3-L523S
mutant. The in vivo defects in pol3-L523S msh2 and pol3-
L523S exo1 double mutants are comparable with those of the
double mutants involving catalytically null pol3-5DV (Table 3,
his7-2 reporter). However, unlike Pol -5DV, the Pol -L523S
mutant enzyme retains 70% of wild-type exonuclease activity,
indicating that the switching defect in this mutant contributes
substantially to the observed phenotypes. In summary, the bi-
ological defects in the pol3-L523X mutants exceeded the level
expected from just a partial deficiency in exonuclease activity.
We conclude that switching from the polymerase to the
exonuclease domain in Pol  is required for its multiple roles in
vivo. As discussed below, this requirement leads us to propose
that the exonuclease mediates its functions primarily within the
holoenzyme complex that is performing DNA synthesis.
Proofreading is performed by the same Pol  molecule that
introduces an error. In principle, the requirement for switch-
ing between the polymerase and exonuclease sites during
proofreading could be bypassed if the polymerase were able to
dissociate from the DNA after making an error, followed by
another enzyme molecule that could bind the mismatch di-
rectly in its exonuclease domain and catalyze degradation.
Such intermolecular proofreading is not in agreement with the
in vivo levels of proofreading defects of the pol3 switching
mutants, as compared to the catalytic null mutants. Specifi-
cally, if intermolecular proofreading involving different Pol 
molecules would be frequent, the proofreading defect in pol3-
L523S should be much smaller than in the catalytically dead
pol3-5DV, while pol3-L523H would not be expected to show
FIG. 5. Three biological functions of the yeast Pol  335 exonu-
clease. Shown are substrates and products resulting from the action of
Pol . (A) Proofreading. Exonuclease removes mismatched or mis-
aligned nucleotide(s) at the 3 terminus. (B) MMR. Exonuclease re-
moves a long stretch of DNA including a mismatch (shown as a trian-
gle) that has not been removed by proofreading. (C) Okazaki
maturation. Exonuclease digests several nucleotides from the 3 ter-
minus of a nascent strand. This allows the 5-displaced strand (thick
line) to realign and create a ligatable nick.
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any significant proofreading defect. We conclude that intramo-
lecular proofreading, i.e., by the same polymerase molecule
that introduced an error, is the prevailing mechanism for
proofreading spontaneous replication errors made by the Pol 
in yeast. Since this conclusion is based upon the phenotypes of
the L523X switching mutants, we currently cannot exclude the
possibility of intermolecular proofreading by wild-type poly-
merase or by other pol3 mutants. For example, errors intro-
duced by the catalytically defective pol3-01 have been pro-
posed to be proofread in the intermolecular mode by the DNA
polymerase that replicates the opposite strand (32, 33). If in-
termolecular Pol /Pol ε proofreading does take place, it does
not fully compensate for proofreading defects in the catalyti-
cally inactive pol3-01 mutant (31, 45).
While we conclude that proofreading is primarily performed
by the same Pol  molecule that introduced an error, the
mechanism by which the replication machinery extends the
DNA strand containing an error remains to be established.
Studies with mutant pol3-01 indicate that replication check-
points and bypass polymerases may be involved in mutation
avoidance in the absence of the Pol  exonuclease (10). An
increased capacity for extension of an error made by Pol
-L523X mutant polymerases may explain why some of them
are showing stronger mutator effects than the catalytically null
pol3-01 or pol3-5DV, as well as the differences in mutator
effects between these two catalytically null polymerases (Table
1). However, we note that up to 99% of the mutator effects in
single pol3 mutants can be masked by replication-associated
mutation avoidance functions, such as Msh2 (mismatch recog-
nition) and Exo1 (mismatch removal). Therefore, the observed
differences in mutator effects of single pol3 mutants could be
due to activities distinct from normal DNA replication such as
DNA repair and translesion synthesis. Studies of mutator ef-
fects and genetic interactions of exonuclease-related pol3 mu-
tations in the absence of MMR may lead to a better under-
standing of factors that determine error extension during
replication.
Role of the Pol  exonuclease in MMR. Biochemical studies
have established that both prokaryotic and eukaryotic MMR
systems remove up to several hundred nucleotides surrounding
a mismatch. In E. coli at least four nucleases and one helicase
were implicated in mismatch removal (reviewed in reference
36). So far, the only enzyme clearly implicated in mismatch
removal in eukaryotes is Exo1, which in the in vitro MMR
assay has been shown to catalyze both 3 and 5 degradation
(see the introduction). The synergistic mutator phenotypes and
synthetic lethality lead us to propose that in yeast, Exo1 and
Pol -Exo provide partially redundant activities for the re-
moval of a mismatch-containing DNA strand during MMR (45
and the introduction). Since Pol  switching is required in
Exo1-related mutation avoidance it is likely that the Pol 
exonuclease functions here also as part of the replicating ho-
loenzyme complex, rather than as a free exonuclease. The most
straightforward explanation of our results is that Exo1 and Pol
 exonuclease have overlapping roles in DNA degradation
during mismatch removal. However, in order to carry out ef-
ficient mismatch removal over hundreds of nucleotides as a
part of holoenzymes attached to DNA, the exonuclease activity
of Pol  should be converted into a processive exonuclease
mode. This could occur upon interaction with the mismatch
recognition complex, similar to the conversion of Exo1 into a
processive exonuclease triggered by MutS (17).
Role of the Pol  exonuclease in Okazaki fragment matura-
tion. Our previous in vivo and in vitro studies have shown that
the exonuclease activity of Pol  is important for efficient
maturation of Okazaki fragments (22, 24). This activity of Pol
 contributes to the prevention of double-strand breaks, ge-
nome rearrangements, and mutations. The exonuclease activ-
ity facilitates the formation of ligatable nicks by reducing the
strand displacement capacity of Pol . We have hypothesized
that there is a balance between strand displacement and 335
degradation within a replication complex, which allows effi-
cient maintenance of a ligatable nick. The synthetic lethality of
the pol3-L523H rad27 double mutant, together with the
strong induction of duplication mutations observed in the via-
ble pol3-L523H rad27-p double mutant, indicate that poly-
merase-to-exonuclease switching is also essential for Okazaki
maturation (Tables 2 and 5). In fact, genetic data suggest that
the weakest switching mutant, pol3-L523H, has only a partial
defect in proofreading and MMR, while its defect in Okazaki
maturation is as strong as that of catalytically null pol3-5DV.
Our recent study has highlighted the importance of switching
between the polymerase and exonuclease domains in order for
Pol  to maintain a ligatable nick in vitro (14). Based on the
current study, we suggest that the same Pol  molecule that
synthesized an Okazaki fragment assists in maintenance of a
ligatable nick in vivo.
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